OTC · Financial Statements

Oncotelic Therapeutics, Inc. (OTLC) Financial Statements

$0.04 OTC: OTLC Market Cap $17.74M

Oncotelic Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $249.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-9.0M$-10.0M$-7.0M$-3.6B$-3.0M
Net Profit$-11.0M$18.0M$-8.0M$-4.5B$249.0M
EPS$-0.04$0.04$-0.02$-0.01$0.59
Op Margin——-9497.2%——

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$24.0M$36.0M$30.0M$27.0M$393.09T
Total Liabilities$15.0M$17.0M$18.0M$19.0M$131.36T
Cash$1.0M$0$0$0$88.9B
Borrowings$9.0M$11.0M$13.0M$13.0M$16.27T

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-1.0M$-1.0M$-1.0M$-1.38T
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$1.0M$0$0$1.39T
Net Cash Flow$0$0$0$0$2.7B
Free Cash Flow$-4.0M$-1.0M$-1.0M$-1.0M$-1.38T

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA48.68
FCF Yield-8.78%
Quick Ratio0.11
Interest Coverage-5.05
Return 1Y-20.00%
Return 3Y100.00%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
OTLC Overview OTLC Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.